AN2 THERAPEUTICS INC shareholder history

Current and past AN2 THERAPEUTICS INC shareholders
Period Weighting Quarter
CompanyLongestShortestMin.Avg.Max.FirstLatest↓ Count
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 770.00%0.00%0.00%Q1 2022Q3 20237
RA Capital Management 770.61%1.04%1.76%Q1 2022Q3 20237
Monashee Investment Management LLC 770.37%1.09%1.89%Q1 2022Q3 20237
MORGAN STANLEY 770.00%0.00%0.00%Q1 2022Q3 20237
BVF INC/IL 770.37%0.71%1.16%Q1 2022Q3 20237
Avidity Partners Management LP 770.12%0.27%0.70%Q1 2022Q3 20237
Citadel Advisors 770.00%0.00%0.01%Q1 2022Q3 20237
BARCLAYS PLC 770.00%0.00%0.00%Q1 2022Q3 20237
Alyeska Investment Group, L.P. 770.00%0.01%0.02%Q1 2022Q3 20237
UBS Group AG 770.00%0.00%0.00%Q1 2022Q3 20237
VANGUARD GROUP INC 770.00%0.00%0.00%Q1 2022Q3 20237
Tower Research Capital LLC (TRC) 510.00%0.00%0.00%Q1 2022Q3 20236
BlackRock Inc. 660.00%0.00%0.00%Q2 2022Q3 20236
STATE STREET CORP 660.00%0.00%0.00%Q2 2022Q3 20236
BANK OF AMERICA CORP /DE/ 660.00%0.00%0.00%Q2 2022Q3 20236
GEODE CAPITAL MANAGEMENT, LLC 660.00%0.00%0.00%Q2 2022Q3 20236
OSAIC HOLDINGS, INC. 660.00%0.00%0.00%Q2 2022Q3 20236
CITIGROUP INC 660.00%0.00%0.00%Q2 2022Q3 20236
NORTHERN TRUST CORP 410.00%0.00%0.00%Q2 2022Q3 20235
ROYAL BANK OF CANADA 550.00%0.00%0.00%Q2 2022Q2 20235
FMR LLC 550.00%0.00%0.00%Q3 2022Q3 20235
NEW YORK STATE COMMON RETIREMENT FUND 550.00%0.00%0.00%Q2 2022Q2 20235
WELLS FARGO & COMPANY/MN 320.00%0.00%0.00%Q2 2022Q3 20235
DEUTSCHE BANK AG\ 440.00%0.00%0.00%Q2 2022Q1 20234
RHUMBLINE ADVISERS 440.00%0.00%0.00%Q4 2022Q3 20234
AMALGAMATED BANK 440.00%0.00%0.00%Q2 2022Q1 20234
Ameritas Investment Partners, Inc. 440.00%0.00%0.00%Q2 2022Q1 20234
JPMORGAN CHASE & CO 440.00%0.00%0.00%Q2 2022Q1 20234
Legal & General Group Plc 440.00%0.00%0.00%Q2 2022Q1 20234
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 440.00%0.00%0.00%Q2 2022Q1 20234
Private Advisor Group, LLC 310.00%0.00%0.01%Q2 2022Q2 20234
AMERICAN INTERNATIONAL GROUP, INC. 440.00%0.00%0.00%Q2 2022Q1 20234
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 440.00%0.00%0.00%Q2 2022Q1 20234
Woodline Partners LP 440.01%0.02%0.04%Q1 2022Q4 20224
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 330.12%0.19%0.25%Q1 2022Q3 20223
SUSQUEHANNA INTERNATIONAL GROUP, LLP 210.00%0.00%0.00%Q2 2022Q3 20233
BRIDGEWAY CAPITAL MANAGEMENT, LLC 330.01%0.01%0.02%Q1 2023Q3 20233
ETF MANAGERS GROUP, LLC 210.00%0.00%0.00%Q2 2022Q1 20233
Bank of New York Mellon Corp 330.00%0.00%0.00%Q3 2022Q1 20233
MILLENNIUM MANAGEMENT LLC 110.00%0.00%0.00%Q1 2022Q2 20232
Octagon Capital Advisors LP 220.85%1.50%2.14%Q2 2023Q3 20232
NISA INVESTMENT ADVISORS, LLC 220.00%0.00%0.00%Q4 2022Q1 20232
TCG Crossover Management, LLC 221.80%4.07%6.34%Q2 2023Q3 20232
JANUS HENDERSON GROUP PLC 220.01%0.01%0.02%Q2 2023Q3 20232
STRS OHIO 220.00%0.00%0.00%Q4 2022Q1 20232
Renaissance Technologies 220.00%0.00%0.00%Q2 2022Q3 20222
Nuveen Asset Management, LLC 220.00%0.00%0.00%Q4 2022Q1 20232
GOLDMAN SACHS GROUP INC 110.00%0.00%0.00%Q1 2022Q2 20232
CREDIT SUISSE AG/ 220.00%0.00%0.00%Q2 2022Q3 20222
COWEN AND COMPANY, LLC 110.09%0.09%0.09%Q1 2022Q1 20221
Qube Research & Technologies Ltd 110.00%0.00%0.00%Q2 2023Q2 20231
CAPTRUST FINANCIAL ADVISORS 110.00%0.00%0.00%Q3 2023Q3 20231
FEDERATED HERMES, INC. 110.00%0.00%0.00%Q3 2023Q3 20231
Integrated Wealth Concepts LLC 110.00%0.00%0.00%Q2 2023Q2 20231
PANAGORA ASSET MANAGEMENT INC 110.00%0.00%0.00%Q3 2022Q3 20221
Frazier Life Sciences Management, L.P. 111.48%1.48%1.48%Q3 2023Q3 20231
Heritage Wealth Advisors 110.00%0.00%0.00%Q3 2023Q3 20231
Y-Intercept (Hong Kong) Ltd 110.01%0.01%0.01%Q2 2023Q2 20231
ACUTA CAPITAL PARTNERS, LLC 110.14%0.14%0.14%Q3 2023Q3 20231
WELLINGTON MANAGEMENT GROUP LLP 110.00%0.00%0.00%Q1 2022Q1 20221
Anson Funds Management LP 110.00%0.00%0.00%Q1 2022Q1 20221
VICTORY CAPITAL MANAGEMENT INC 110.00%0.00%0.00%Q3 2023Q3 20231
MARSHALL WACE, LLP 110.02%0.02%0.02%Q3 2023Q3 20231
Invesco Ltd. 110.00%0.00%0.00%Q3 2023Q3 20231
RMB Capital Management, LLC 110.02%0.02%0.02%Q3 2023Q3 20231
Nantahala Capital Management 110.49%0.49%0.49%Q3 2023Q3 20231
ADAGE CAPITAL PARTNERS GP, L.L.C. 110.03%0.03%0.03%Q3 2023Q3 20231

This page lists all the filers that currently own AN2 THERAPEUTICS INC or have owned AN2 THERAPEUTICS INC in the past.